Previous close | 126.11 |
Open | 126.81 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 1200 |
Day's range | 125.97 - 128.54 |
52-week range | 71.51 - 141.54 |
Volume | |
Avg. volume | 838,779 |
Market cap | 11.161B |
Beta (5Y monthly) | 1.05 |
PE ratio (TTM) | 17.23 |
EPS (TTM) | 7.42 |
Earnings date | 02 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 132.00 |
Masimo's (MASI) R&D activities raise optimism about the stock.
CVRx's (CVRX) announcement of the availability of additional data supporting the long-term benefits of Barostim is likely to lead to improved patient care.
GE HealthCare (GEHC) announces its latest AI-powered Voluson Signature 20 and 18 ultrasound systems, which are likely to provide effective and efficient care for conditions impacting women's health.